![](https://i-invdn-com.investing.com/news/LYNXNPEC0D0AP_L.jpg)
Earnings call: BioMarin confirms progress and raises full-year guidance
BioMarin Pharmaceuticals Inc. (BMRN) reported a successful second quarter in 2024, with significant advancements in its product portfolio and financial performance. The company announced strong quarterly results, including record total revenue of $712 …